Observational studies in humans showed that IL-13 serum levels correlate with improved ventricular function in ischemic patients with HF (29), while levels of the type II IL-13 receptor heterodimer, IL-4Rα/IL-13Rα1, are decreased in patients with HF (30). This evidence concerns the gene IL4R and hydrops fetalis.